Now operating as Owlstone Medical, this company is a global leader in Breath Biopsy(R) for early disease detection and precision medicine. They have pioneered a chemical sensor platform based on a micro-fabricated field-asymmetric ion mobility spectrometer (FAIMS) on a chip, which can detect volatile organic compounds (VOCs) in breath.
Cambridge
2004
51–200
